Clinical Trial Update: Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the safety and efficacy of FAP iCDC in patients with acute myocardial infarction complicated by cardiogenic shock; study not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• FAP iCDC

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction | Phase 1 | Status: NOT_YET_RECRUITING